-+ 0.00%
-+ 0.00%
-+ 0.00%
Virax Biolabs signs Fosun Diagnostics supply deal for ImmuneSelect in six Southeast Asian markets
Share
Listen to the news
Virax Biolabs signs Fosun Diagnostics supply deal for ImmuneSelect in six Southeast Asian markets
  • Virax Biolabs entered a commercial supply agreement with Fosun Diagnostics for ImmuneSelect across six Southeast Asian markets.
  • Deal targets near-term commercial supply and evaluation activity, with initial focus on tuberculosis-related research applications in Thailand.
  • Management flagged potential regional expansion through Fosun’s network as it seeks to translate ImmuneSelect demand into revenue.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Virax Biolabs Group Ltd. published the original content used to generate this news brief on July 16, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending